Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
102.01
+1.75 (1.75%)
Sep 25, 2026, 3:29 PM IST
NSE:AAREYDRUGS Market Cap
NSE:AAREYDRUGS has a market cap or net worth of 2.85 billion as of September 25, 2026. Its market cap has increased by 27.56% in one year.
Market Cap
2.85B
Enterprise Value
3.43B
Revenue
4.15B
Ranking
n/a
PE Ratio
78.81
Stock Price
102.01
ChartMarket Cap Chart
Since April 17, 2007, NSE:AAREYDRUGS's market cap has increased from 147.01M to 2.85B, an increase of 1,840.54%. That is a compound annual growth rate of 16.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 2.85B | 48.14% |
| Dec 31, 2025 | 1.93B | 21.48% |
| Dec 31, 2024 | 1.59B | 23.59% |
| Dec 29, 2023 | 1.28B | 30.23% |
| Dec 30, 2022 | 984.93M | -9.47% |
| Dec 31, 2021 | 1.09B | 26.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.88B |
| Sigachi Industries | 11.70B |
| Bafna Pharmaceuticals | 7.81B |
| Amanta Healthcare | 7.20B |
| Valiant Laboratories | 6.87B |
| Nectar Lifesciences | 2.10B |
| Brooks Laboratories | 1.74B |
| Par Drugs and Chemicals | 1.70B |